Joshua D. Levin

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

Anna K. Füzéry, Joshua D. Levin, Maria Chan et al. · Clinical Proteomics · 2013 · 424 citations · Full text

Medicine, Biochemistry, Oncology +17

Homogeneous Escherichia coli endonuclease IV. Characterization of an enzyme that recognizes oxidative damage in DNA.

Joshua D. Levin, Alan M. Johnson, Bruce Demple · Journal of Biological Chemistry · 1988 · 183 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Analysis of class II (hydrolytic) and class I (β-lyase) apurinic/apyrimidinic endonucleases with a synthetic DNA substrate

Joshua D. Levin, Bruce Demple · Nucleic Acids Research · 1990 · 90 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Position-dependent effects of locked nucleic acid (LNA) on DNA sequencing and PCR primers

Joshua D. Levin, Dean Fiala, M Samala et al. · Nucleic Acids Research · 2006 · 69 citations · Full text

Life Sciences, Biology, Molecular Biology +13

Protein-Based Multiplex Assays: Mock Presubmissions to the US Food and Drug Administration

Fred E. Regnier, Steven J. Skates, Mehdi Mesri et al. · Clinical Chemistry · 2009 · 61 citations · Full text

Life Sciences, Biochemistry, Oncology +17